Walleye Capital LLC Jasper Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $54.3 Billion
- Q2 2024
A detailed history of Walleye Capital LLC transactions in Jasper Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 14,000 shares of JSPR stock, worth $304,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$304,640% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding JSPR
# of Institutions
1Shares Held
5.63MCall Options Held
0Put Options Held
0About Jasper Therapeutics, Inc.
- Ticker JSPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,073,300
- Market Cap $807M
- Description
- Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...